Verition Fund Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-39,201
Closed -$491K – 3258
2024
Q1
$491K Buy
+39,201
New +$507K ﹤0.01% 2014
2023
Q4
– Sell
-10,013
Closed -$147K – 2672
2023
Q3
$147K Buy
+10,013
New +$156K ﹤0.01% 2057
2017
Q4
– Sell
-14,513
Closed -$326K – 1220
2017
Q3
$326K Buy
+14,513
New +$328K 0.03% 819
2017
Q1
– Sell
-8,692
Closed -$214K – 1451
2016
Q4
$214K Buy
+8,692
New +$183K 0.02% 1009

Other funds holding TBI

Verition Fund Management's TBI Position: Q2 2024 in Review

Verition Fund Management sold out of Trueblue (TBI) in Q2 2024, closing a stake of 39,201 shares — an estimated $491K sold.

Verition Fund Management first reported a position in TBI in Q4 2016 and held it in 4 quarters. The position peaked at $491K in Q1 2024. 121 funds tracked by Wall St. Rank hold TBI as of Q2 2024.

  • Verition Fund Management reported no remaining Trueblue position as of Q2 2024 after selling out during the quarter.
  • Verition Fund Management sold 39,201 Trueblue shares in Q2 2024, an estimated $491K.
  • Verition Fund Management first reported a position in Trueblue in Q4 2016 and held it in 4 quarters.
  • Verition Fund Management's Trueblue position peaked at $491K in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Trueblue as of Q2 2024.

Based on Verition Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.